
The development of new orally administered anticoagulants, such as dabigatran, rivaroxaban, and apixaban, in the past few years has focused on avoiding some of the drawbacks associated with warfarin. This work aims to illustrate the main features of the most commonly used new oral anticoagulants, reviewing the current literature on the management of patients taking these drugs and needing oral and implant surgery, and discussing the currently proposed related guidelines.
Pyridones, Oral Surgical Procedures, Administration, Oral, Anticoagulants, Oral Hemorrhage, Antithrombins, Dabigatran, Rivaroxaban, Dental Care for Chronically Ill, Humans, Pyrazoles, Warfarin, Factor Xa Inhibitors
Pyridones, Oral Surgical Procedures, Administration, Oral, Anticoagulants, Oral Hemorrhage, Antithrombins, Dabigatran, Rivaroxaban, Dental Care for Chronically Ill, Humans, Pyrazoles, Warfarin, Factor Xa Inhibitors
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 20 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
